Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study

Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study

Ocrelizumab (OCR) and Natalizumab (NTZ) are highly effective treatments widely used in Multiple Sclerosis (MS). However, long-term, real-world comparative data on clinical effectiveness, safety and treatment persistence are limited. This retrospective analysis included relapsing and progressive MS p...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Elena Barbuti, Alessia Castiello, Valeria Pozzilli, Antonio Carotenuto, Ilaria Tomasso, Marcello Moccia, Serena Ruggieri, Giovanna Borriello, Roberta Lanzillo, Vincenzo Brescia Morra, Carlo Pozzilli, Maria Petracca
Format: Artykuł
Język:English
Wydane: Elsevier 2025-03-01
Seria:Neurotherapeutics
Hasła przedmiotowe:
Multiple sclerosis
Natalizumab
Ocrelizumab
Real-world
Effectiveness
Safety
Dostęp online:http://www.sciencedirect.com/science/article/pii/S1878747925000157

Internet

http://www.sciencedirect.com/science/article/pii/S1878747925000157

Podobne zapisy